A detailed history of American Assets Inc transactions in Biogen Inc. stock. As of the latest transaction made, American Assets Inc holds 2,000 shares of BIIB stock, worth $298,040. This represents 0.13% of its overall portfolio holdings.

Number of Shares
2,000
Holding current value
$298,040
% of portfolio
0.13%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$189.07 - $236.8 $378,140 - $473,600
2,000 New
2,000 $387,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track American Assets Inc Portfolio

Follow American Assets Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Assets Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Assets Inc with notifications on news.